Skip to main content
. 2012 Jan;73(1):93–105. doi: 10.1111/j.1365-2125.2011.04049.x

Figure 2.

Figure 2

Study design and patient disposition. Ninety subjects received ≥1 dose of study drug. In period 1, 45 subjects completed 10 days of prasugrel and 41 subjects completed 10 days of clopidogrel. In period 2, 43 subjects completed 10 days of clopidogrel and 40 subjects completed 10 days of prasugrel. Clop, clopidogrel; n, number of subjects; Pras, prasugrel